rcs semaglutide – Research Peptide month semaglutide micro Semaglutide & Weight Loss |

Ozempic butt may be visually described as the flattening or sagging of the buttocks

*, P 0.05)

Steinherz PG, Redner A, Haimi J, Meyers P, Andreeff M

Advantages: Minimizes overlapping GLP-1 receptor activation Reduces nausea risk during first tirzepatide dose Allows clear attribution of side effects to the new medication Disadvantages: 7 to 10 day gap in appetite suppression Some patients report increased hunger and modest weight regain (1 to 3 pounds) during washout Psychological difficulty for patients who rely on medication for appetite control Clinical data supporting washout: a 2025 retrospective study (Kushner et al., Obesity Science & Practice) found no difference in final weight-loss outcomes between washout and overlap strategies, but washout patients reported 18% lower nausea rates during the first month of tirzepatide

Modest weight reductions can occur with SGLT2 inhibitors, while GLP1 agents generally show more pronounced weight effects, although responses vary

Based on typical dysesthesia patterns, likely affected: Hands and feet most commonly Arms and legs Face or scalp less commonly Trunk rarely What We DON'T Know Does it resolve over time